Literature DB >> 11788658

Molecular distribution of IGF binding protein-5 in human serum.

Robert C Baxter1, Sridevi Meka, Sue M Firth.   

Abstract

IGF binding protein-5 (IGFBP-5) forms ternary complexes with IGFs and the acid-labile subunit (ALS) in vitro, but these complexes have not been demonstrated in the circulation. To examine the molecular distribution of circulating IGFBP-5 we developed an RIA with high specificity for IGFBP-5 among the IGFBPs, but wide cross-reactivity among primate and nonprimate species. The mean serum IGFBP-5 level (+/-SD) was 208 +/- 73 ng/ml in healthy men and 206 +/- 67 ng/ml in nonpregnant women, decreasing to 114 +/- 38 ng/ml in pregnancy. Approximately 55% of immunoreactive IGFBP-5 was associated with ternary complexes in nonpregnant adults, whereas only 35% was in these complexes in pregnancy serum. After transient acidification, all immunoreactive IGFBP-5 corresponded in size to free or binary-complexed protein. Serum IGFBP-5 levels were significantly associated with ALS levels (r = 0.478; P = 0.008), but the association was less than that between IGFBP-3 and ALS (r = 0.743; P < 0.001), reflecting the lower percentage of IGFBP-5 complexed with ALS. As free or binary complexed IGFBP-5 is a relatively high proportion of the total, we speculate that, alone or as a carrier of IGFs, IGFBP-5 might have preferential access to the tissues, where it could act to stimulate growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788658     DOI: 10.1210/jcem.87.1.8151

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice.

Authors:  Dervis A M Salih; Subburaman Mohan; Yuji Kasukawa; Gyanendra Tripathi; Fiona A Lovett; Neil F Anderson; Emma J Carter; Jon E Wergedal; David J Baylink; Jennifer M Pell
Journal:  Endocrinology       Date:  2004-11-18       Impact factor: 4.736

2.  Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration.

Authors:  Hidekata Yasuoka; Zhihong Zhou; Joseph M Pilewski; Tim D Oury; Augustine M K Choi; Carol A Feghali-Bostwick
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 3.  IGF binding proteins in cancer: mechanistic and clinical insights.

Authors:  Robert C Baxter
Journal:  Nat Rev Cancer       Date:  2014-04-10       Impact factor: 60.716

4.  Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice.

Authors:  Dervis A M Salih; Gyanendra Tripathi; Cathy Holding; Tadge A M Szestak; M Ivelisse Gonzalez; Emma J Carter; Laura J Cobb; Joan E Eisemann; Jennifer M Pell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

5.  Investigation of the binding network of IGF-I on the cavity surface of IGFBP4.

Authors:  Xin Chen; Shuyan Zhu; Danhui Duan; Tao Wu; Qi Wang
Journal:  J Mol Model       Date:  2013-10-17       Impact factor: 1.810

6.  Pitavastatin Regulates Ang II Induced Proliferation and Migration via IGFBP-5 in VSMC.

Authors:  Yu Mi Ha; Ju-Ock Nam; Young Jin Kang
Journal:  Korean J Physiol Pharmacol       Date:  2015-10-16       Impact factor: 2.016

7.  IGFBP-5 Promotes Fibrosis via Increasing Its Own Expression and That of Other Pro-fibrotic Mediators.

Authors:  Xinh-Xinh Nguyen; Lutfiyya Muhammad; Paul J Nietert; Carol Feghali-Bostwick
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-15       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.